These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5083452)

  • 1. Master and batch records in parenteral product manufacture.
    Syverson JA
    Bull Parenter Drug Assoc; 1972; 26(5):239-46. PubMed ID: 5083452
    [No Abstract]   [Full Text] [Related]  

  • 2. Certification Scheme on the Quality of Pharmaceutical Products moving in International Commerce.
    WHO Chron; 1977 Dec; 31(12):suppl 1-19. PubMed ID: 602166
    [No Abstract]   [Full Text] [Related]  

  • 3. [Quality control in the pharmaceutical industry].
    Sloot HA
    Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061
    [No Abstract]   [Full Text] [Related]  

  • 4. Manufacturing error in a propofol vial: glass within glass.
    Umesh G; Kaur N
    J Clin Anesth; 2012 Dec; 24(8):677. PubMed ID: 23228875
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hygienic precautions and microbiological quality control during the manufacturing of sterile drugs].
    Züge R
    Zentralbl Bakteriol Mikrobiol Hyg B; 1982 May; 176(2-3):134-41. PubMed ID: 7124163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and classification of nonconformities in molded and tubular glass containers for pharmaceutical manufacturing. Technical report No. S-3 2007.
    Parenteral Drug Association
    PDA J Pharm Sci Technol; 2007; 61(3 Suppl TR43):2-20. PubMed ID: 18154190
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk analysis in the manufacture of veterinary biologicals.
    Moreau Y
    Rev Sci Tech; 1995 Dec; 14(4):937-50. PubMed ID: 8639962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh.
    Amran S; Ahmed M; Shaheen SM; Morshed SN; Khandakar J; Rahman M; Rahman M; Hossain A
    Pak J Pharm Sci; 2007 Oct; 20(4):327-32. PubMed ID: 17604258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helping your patients avoid counterfeit medicines.
    Teichman PG
    Fam Pract Manag; 2007 Mar; 14(3):33-5. PubMed ID: 17408128
    [No Abstract]   [Full Text] [Related]  

  • 10. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Requirements of the iks (intercantonal control agency) guide lines].
    Zinn W
    Pharm Acta Helv; 1973 Jan; 48(1):1-21. PubMed ID: 4696262
    [No Abstract]   [Full Text] [Related]  

  • 11. Current good manufacturing practice regulations.
    Bumiller J
    Bull Parenter Drug Assoc; 1971; 25(5):222-5. PubMed ID: 5094094
    [No Abstract]   [Full Text] [Related]  

  • 12. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in medium-size plants].
    Schlumpf R
    Pharm Acta Helv; 1973 Jan; 48(1):22-36. PubMed ID: 4696263
    [No Abstract]   [Full Text] [Related]  

  • 13. Panel discussion: in process control and inspection for quality assurance. I.
    Shea JJ
    Bull Parenter Drug Assoc; 1968; 22(2):82-7. PubMed ID: 5649570
    [No Abstract]   [Full Text] [Related]  

  • 14. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 15. Adequate and sensible quality control.
    Schoulund B
    J Ir Med Assoc; 1968 Oct; ():Suppl 1:21. PubMed ID: 5701294
    [No Abstract]   [Full Text] [Related]  

  • 16. Panel discussion: in process control and inspection for quality assurance. 3.
    Brofazi FR
    Bull Parenter Drug Assoc; 1968; 22(2):90-6. PubMed ID: 5649572
    [No Abstract]   [Full Text] [Related]  

  • 17. Proposed rule: current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements.
    Melethil S
    Life Sci; 2006 Mar; 78(18):2049-53. PubMed ID: 16516243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panel discussion: in process control and inspection for quality assurance. II.
    Hofer AJ
    Bull Parenter Drug Assoc; 1968; 22(2):87-90. PubMed ID: 5649571
    [No Abstract]   [Full Text] [Related]  

  • 19. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of vendors and drug-product selection.
    Dedrick SC; Eckel FM
    Am J Hosp Pharm; 1984 Apr; 41(4):703-8. PubMed ID: 6720713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.